| Term 
 | Definition 
 
        | Acts on target tissues (esp liver) through JAK2 (a TK) to initiated signalling pathways; Production of IGF-1(&2) to exert effects;
 Dec insulin sens, inc lipolysis, inc protein synth, inc epiphyseal growth;
 Secretion stimulated by hypoglycemia, insulin;
 Physiologic pulsatile release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hGH; Replacement therapy in children;
 Tx child - pituitary dwarfism (d/c when growth stops);
 Tx adults - CV dz mortality, AIDS-associated wasting;
 SE child (fewer) - leukemia, inc ICP, nausea;
 SE adult - carpal tunnel, peripheral edema, arthralgia, myalgia;
 CI - leukemia tx
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hGH + methionine; Replacement therapy in children;
 Tx child - pituitary dwarfism (d/c when growth stops);
 Tx adults - CV dz mortality, AIDS-associated wasting;
 SE child (fewer) - leukemia, inc ICP, nausea;
 SE adult - carpal tunnel, peripheral edema, arthralgia, myalgia;
 CI - leukemia tx
 |  | 
        |  | 
        
        | Term 
 
        | Sermorelin acetate (Geref) |  | Definition 
 
        | GHRH, short form; First 29 AA;
 Diagnostic uses
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GH receptor antagonist; Dec IGF-1;
 +Polyethylene glycol (PEG) to dec renal cl, inc t1/2;
 Tx acromegaly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IGF-1 + IGFBP-3 (both recombinant humaniod); Binding protein - inc t1/2 of IGF-1;
 Tx IGF-deficiency
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rises during pregnancy til birth; Lvls maintained for breast feeding, drop if no feeding;
 Know symptoms of hyperprolactemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 receptor agonist; Dec prolactin production @ ant. pituitary;
 Cheap
 Tx hyperprolactinemia from pit. adenoma, Parkinson's (primary use)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 receptor agonist; Dec prolactin production @ ant. pituitary;
 Inc affinity, inc t1/2;
 Tx hyperprolactinemia from pit. adenoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Somatostatin analog; Dec secretion of GH and TSH;
 Short t1/2;
 Tx gigantism/acromegaly;
 SE - diarrhea, nausea, abdominal pain
 |  | 
        |  | 
        
        | Term 
 
        | Lanreotide (Somatuline LA) |  | Definition 
 
        | Somatostatin analog; Dec secretion of GH and TSH;
 Long-acting;
 Tx gigantism/acromegaly;
 SE - diarrhea, nausea, abdominal pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glycoprotein hormone released in ant. pituitary; Stim by TRH and dec iodine, inhibited by somatostatin;
 Inc release of T4,T3 secretion, THEN synthesis;
 Thyroid hypertrohpy, hyperplasia;
 High lvls - stim of phospholipase C - inc cystolic Ca;
 Admin for dx tool to distinguish 1* from 2* hypothyroid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glycoprotein hormone released in ant. pituitary; Men @ Leydig cells to stimulate androgen production, spermatogenesis;
 Women, a spike will induce ovulation;
 Release stim by GnRH
 |  | 
        |  | 
        
        | Term 
 
        | Follicle-stimulating hormone (FSH) |  | Definition 
 
        | Glycoprotein hormone released in ant. pituitary; Release stim by GnRH;
 Female - gametogenesis and follicle development, used in replacement;
 Male - initiation and maintenance of spermatogenesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | FSH + LH; Extracted from post-menopausal urine;
 IM admin;
 Tx female infertility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SC admin; Tx female infertility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rFSH; SC admin;
 Tx female infertility
 |  | 
        |  | 
        
        | Term 
 
        | Chorionic gonadotropin (CG) |  | Definition 
 
        | Secreted by placenta in early pregnancy; Detected in urine to dx pregnancy;
 Extracted from prego's urine - Tx female infertility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Corticotropin (ACTH) alpha-MSH and beta-MSH (melanocyte stimulating hormone)
 |  | 
        |  | 
        
        | Term 
 
        | Melanocyte-stimulating hormones (MSH) |  | Definition 
 
        | POMC-deriv from ant. pituitary; Inc production concurrent w/ inc ACTH production leads to hyperpigmentation
 |  | 
        |  | 
        
        | Term 
 
        | Growth hormone-releasing hormone (GHRH) |  | Definition 
 
        | Hypothalamic stimulatory hormone; Inc GH release;
 Negative feedback by rising GH lvls;
 Used to determine the cause of GH deficiency
 |  | 
        |  | 
        
        | Term 
 
        | Gonadotropin-Releasing Hormone (GnRH) |  | Definition 
 
        | Hypothalamic stimulatory hormone; Stimulates FSH, LH production;
 |  | 
        |  | 
        
        | Term 
 
        | Gonadorelin hydrochloride (Factrel) |  | Definition 
 
        | Synthetic GnRH; SHORT t1/2;
 Diagnostic testing to diff pituitary and hypothalamic lesions in pts w/ hypogonadotropism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH analog; Inc t1/2, inc receptor binding - induces receptor downregulation;
 Tx prostate cancer, uterine fibroids
 |  | 
        |  | 
        
        | Term 
 
        | Thyrotropin-releasing hormone (TRH) |  | Definition 
 
        | Diagnostic testing of thyroid function; Stimulates TSH and prolactin |  | 
        |  | 
        
        | Term 
 
        | Corticotropin-releasing hormone (CRH) |  | Definition 
 
        | Diagnostic testing to diff Cushings Dz from ectopic ACTH syndrome |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | POMC-deriv(39AA) from ant. pituitary; Works at G-protein coupled receptor to stimulate AC to produce cAMP;
 Use - test integrity of HPA axis
 |  | 
        |  | 
        
        | Term 
 
        | Regulation of ACTH release (4 routes) |  | Definition 
 
        | Circadian rhythm; (+) stress (overriding)
 (-) cortisol @ pit and hypothalamus;
 (-) ACTH
 |  | 
        |  | 
        
        | Term 
 
        | Natural ACTH (H.P. Acthar Gel) |  | Definition 
 
        | From animal sources, POMC peptide; Use - test integrity of HPA axis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic ACTH (24 AA); Preferred to natural product b/c no vasopressin activity;
 Use - test integrity of HPA axis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Produced in adrenal cortex; Stimulate gluconeogenesis, glycogenolysis;
 Anti-inflammatory, acts by dec Phospholipase A2, dec cytokines, dec histamine;
 Periphery - [oppose insulin] dec glu use, inc proteolysis, lipolysis;
 Mostly delayed effects;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Suppression of ACTH and TSH production; Inc lipolysis, redistribute fat;
 Inc DM risk (opposes insulin);
 Peptic ulcers;
 CNS - arousal, euphoria, insomnia, inc motor activity;
 Blood - inc Hgb RBCs PMNs, dec lymphocytes eosinophils monocytes basophils;
 Men - hypogonadism;
 Women - stops ovulation, dysmenorrhea, osteoporosis (post-men);
 Children - inh IGF-1, dec GH, osteoporosis;
 Lose Ca++
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Produced in adrenal cortex (10mg/day); Stimulate gluconeogenesis, glycogenolysis;
 Anti-inflammatory, acts by dec Phospholipase A2, dec cytokines, dec histamine;
 Periphery - [oppose insulin] dec glu use, inc proteolysis, lipolysis;
 Mostly delayed effects;
 90% bound to CBP or albumin;
 Converted (kidney, colon, salivary glands) to cortisone - won't bind MC receptors;
 |  | 
        |  | 
        
        | Term 
 
        | Hydrocortisone (Hydrocortone) |  | Definition 
 
        | Glucocorticoid; Short t1/2;
 IM, IV, oral admin;
 Tx replacement therapy for adrenal insuff. and CAH, ALL, lymphoma, skin dz, IBD
 |  | 
        |  | 
        
        | Term 
 
        | Cortisone acetate (Cortone acetate) |  | Definition 
 
        | Glucocorticoid; Short t1/2;
 IM, IV, oral admin;
 Tx replacement therapy for adrenal insuff. and CAH, ALL, lymphoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glucocorticoid; Med t1/2;
 Oral admin;
 Tx replacement therapy for adrenal insuff. and CAH, ALL, lymphoma, RHEUMATIC dz, RENAL dz, IBD, HEPATIC dz
 |  | 
        |  | 
        
        | Term 
 
        | Prednisolone (Delta-Cortef) |  | Definition 
 
        | Glucocorticoid; Med t1/2;
 IM, IV admin;
 Tx replacement therapy for adrenal insuff. and CAH, ALL, lymphoma, HEPATIC dz
 |  | 
        |  | 
        
        | Term 
 
        | Methylprednisolone (Medrol) |  | Definition 
 
        | Glucocorticoid; Med t1/2;
 IM, IV, oral admin;
 Tx replacement therapy for adrenal insuff. and CAH, ALL, lymphoma;
 Gen immunosuppression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glucocorticoid; Long t1/2;
 IM, IV, topical, oral admin;
 Tx replacement therapy for adrenal insuff. and CAH, ALL, lymphoma, OCULAR DZ
 |  | 
        |  | 
        
        | Term 
 
        | Betamethasone (Celestone) |  | Definition 
 
        | Glucocorticoid; Long t1/2;
 Oral, topical admin;
 Tx asthma
 |  | 
        |  | 
        
        | Term 
 
        | Triamcinolone (Aristocort) |  | Definition 
 
        | Glucocorticoid; Long t1/2;
 Oral, topical admin;
 Tx asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glucocorticoid; Dec mucus secretion, dec bronch hyperactivity;
 Tx asthma, COPD, IBD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mineralocorticoid (0.125 mg/day); Na/water retention, K&H secretion @DCT;
 Inc ECF, hypoK (muscle weakness), alkalosis;
 Inc synthesis of adrenergic receptors;
 Stimulated by angII, inc K, ACTH;
 SE - edema, HTN, cardiomyopathy, CHF, hemorrhage;
 |  | 
        |  | 
        
        | Term 
 
        | Fludrocortisone (Florinef) |  | Definition 
 
        | Mineralocorticoid - synthetic Aldo; Na/water retention, K&H secretion @DCT;
 Inc ECF, hypoK (muscle weakness), alkalosis;
 SE - edema, HTN, cardiomyopathy, CHF, hemorrhage;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aldoesterone antagonist - K-sparing diuretic; |  | 
        |  | 
        
        | Term 
 
        | Aminoglutethimide (Cytadren) |  | Definition 
 
        | Adrenocortical "inhibitor"; Inhibits CYP450 - Dec cortisol production;
 Tx Cushings
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal - secondary Adrenocortical "inhibitor"; Inhibits CYP450 - Dec cortisol production;
 Inh testosterone production;
 Tx Cushings, systemic fungal infections
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Estradiol, estrone, estriol; 70% bound to SHBG;
 Reproductive - birth control, inc libido;
 MC - closes epiphysis, dec osteoclasts, inc bone maturation, inc muscle content;
 Hepatic - inc clotting factors, binding proteins;
 Lipids - inc HDL, dec LDL;
 High first pass met, dec p.o. efficacy;
 Tx - osteoporosis, prostate cancer, HRT;
 SE - endomet. cancer risk, thromboembolism, HTN, GI, CHD;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Locations - female reproductive tract; affects transcription
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Locations - prostate and ovary; affects transcription
 |  | 
        |  | 
        
        | Term 
 
        | Ethinyl estradiol (Estinyl) |  | Definition 
 
        | Estrogen - synthetic 17alpha; Dec first pass met;
 Tx CONTRACEPTION (most common Rx)
 |  | 
        |  | 
        
        | Term 
 
        | Mestranol (ethinyl estradiol 3-methylether) |  | Definition 
 
        | Estrogen - synthetic 17alpha; Dec first pass met;
 Tx CONTRACEPTION (most common Rx)
 |  | 
        |  | 
        
        | Term 
 
        | Conjugated esters of estrogen (Premarin) |  | Definition 
 
        | Pregnant mare urine; IM injection - dec first pass met.;
 Dissolved in oil - absorbed over several weeks;
 Tx sypmtoms of menopause, HRT
 |  | 
        |  | 
        
        | Term 
 
        | Esters of estradiol (Delestrogen) |  | Definition 
 
        | IM injection - dec first pass met.; Dissolved in oil - absorbed over several weeks;
 Tx sypmtoms of menopause, HRT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Crystalline estrone sulfate; Estrogen formulation for standard tx's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-steroidal estrogen; Dec first pass met.;
 Tx prostate cancer, birth control;
 Can be admin transdermally;
 SE - teratogenic!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-steroidal estrogen; Dec first pass met.;
 Tx prostate cancer, birth control;
 Can be admin transdermally;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rises after ovulation to maintain pregnancy; Bound to transcortin for transport;
 Reproductive - dec uterine contraction & oviduct motility, thick cervical mucus, alveolobular dev (breast);
 Lipids - dec HDL, inc LDL;
 Metabolic - inc insulin, inc lipoprotein lipase;
 SE - CAD, CNS depressant, acne, weight gain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic progesterone; Tx endometrial cancer, component of birth control
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic progesterone; Tx endometrial cancer, component of birth control
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic progesterone; Morning-after pill, first 72 hours post-intercourse;
 Tx endometrial cancer, component of birth control
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM; Agonist in bone, brain, liver;
 Antagonist in breast, endometrium;
 Tx breast & endometrial cancers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM; Agonist in bone, brain, liver;
 Antagonist in breast, endometrium;
 Tx breast & endometrial cancers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM; Agonist in bone, brain, liver;
 Antagonist in breast, endometrium;
 Tx breast & endometrial cancers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-estrogen; Antagonist in all tissues (ER-alpha & -beta);
 Ovulation induction via reflex inc GnRH;
 Tx infertility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-estrogen; Antagonist in all tissues (ER-alpha & -beta);
 Ovulation induction via reflex inc GnRH;
 Tx infertility
 |  | 
        |  | 
        
        | Term 
 
        | Mifepristone (Mifeprex) - RU 486 |  | Definition 
 
        | Anti-progestin; Blocks P receptor for the termination of gestation in first 7 weeks
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-progestin - pure antagonist; Blocks P receptor for the termination of gestation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aromatase inhibitor; Block production of estrogens from androgens;
 Tx breast cancer after Tamoxifen fails
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aromatase inhibitor; Block production of estrogens from androgens;
 Tx breast cancer after Tamoxifen fails
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Androgen; [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, PMS, anabolic steroids;
 SE - masculinization, virilization, CAD, hepatic carcinoma, suppression of LH & FSH
 |  | 
        |  | 
        
        | Term 
 
        | Testosterone trasdermal (Testoderm) |  | Definition 
 
        | Testosterone derivative; Good efficacy due to no first pass met., "better" than oral or IM routes;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 
        | Methyltestosterone (Oretin methyl) |  | Definition 
 
        | Testosterone derivatve; Oral, short acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Testosterone derivatve; IM, short acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 
        | Testosterone cypionate (Depo-testosterone) |  | Definition 
 
        | Testosterone derivatve; IM, long acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis,  anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 
        | Testosterone enanthate (Delatestryl) |  | Definition 
 
        | Testosterone derivatve; IM, long acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 
        | Fluoxymesterone (Halotestin) |  | Definition 
 
        | Testosterone derivatve; Oral, short acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Testosterone derivatve; IM, long acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx ENDOMETRIOSIS, elderly men (inc muscle mass), IM injection for HRT, endometriosis, PMS, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 
        | Cyproterone acetate (Cyprostat) |  | Definition 
 
        | Androgen receptor antagonist; Competes with DHT;
 Tx acne, baldness, virilizing syndrome, sexual deviants (dec libido)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Androgen receptor antagonist; Tx prostate cancer;
 SE - hepatotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Androgen receptor antagonist; Tx prostate cancer;
 SE - hepatotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Androgen receptor antagonist; Tx prostate cancer;
 Less hepatotoxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | (also Propecia); Blocks testo conversion (5alpha reductase) to DHT;
 Tx BPH, male-pattern baldness;
 SE - teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insulin-dependent glucose transporter |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Animal insulin used for replacement therapy; Differs from human insulin at 1 AA;
 Dec use due to the equally affordable human insulin;
 Antibodies to drug can develop
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Animal insulin used for replacement therapy; Differs from human insulin at 3 AA;
 Dec use due to the equally affordable human insulin;
 Antibodies to drug can develop
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Animal insulin used for replacement therapy; Differs from human insulin at 3 AA;
 Dec use due to the equally affordable human insulin;
 Antibodies to drug can develop
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insulin activity w/ intermed duration; Injected 2x daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Intermed-duration insulin combined w/ short-acting injected before meals; Dec post-prandial spike and provides longer-acting insulin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 30% semilente and 70% ultralente zinc insulin crystals; Provides short and long term benefits;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short acting insulin crystals included in 'Lente' preparation; |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Long acting insulin crystals included in 'Lente' preparation; Long acting = large crystals
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Recombinant "regular" human insulin; Made in bacteria or yeast;
 Limited anti-insulin Ab's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Recombinant "regular" human insulin; Synthesized beg. with porcine insulin and replacing the 1 different AA;
 Limited anti-insulin Ab's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short acting insulin prep; Synthesized beg. w/ Humulin, 1 AA replaced (via rDNA) to prevent hexamer formation w/ zinc;
 End product - faster onset, short t1/2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short acting insulin prep; Synthesized beg. w/ Humulin, 1 AA replaced (via rDNA) to prevent hexamer formation w/ zinc;
 End product - faster onset, short t1/2
 |  | 
        |  | 
        
        | Term 
 
        | Insulin glargine (Lantus) |  | Definition 
 
        | Long acting insulin prep; 1 AA substituted, + Arg at C-term;
 Prepared in acidic solution - Crystals precipitate upon injection - SLOW ABSORPTION;
 PK - Slow release - long plateau w/ no peaks;
 |  | 
        |  | 
        
        | Term 
 
        | Insulin detemir (Levemir) |  | Definition 
 
        | Long acting insulin prep; 1 AA substituted;
 Prepared in acidic solution - Crystals precipitate upon injection - SLOW ABSORPTION;
 PK - Slow release - long plateau w/ no peaks;
 |  | 
        |  | 
        
        | Term 
 
        | Insulin glulisine (Apidra) |  | Definition 
 
        | Short acting insulin prep; Synthesized beg. w/ Humulin, 2 AAs replaced (via rDNA) to prevent hexamer formation w/ zinc;
 End product - faster onset, short t1/2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Sulfonylurea; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 
        | Chlorpropamide (Diabinese) |  | Definition 
 
        | 1st Gen. Sulfonylurea; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Sulfonylurea; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Sulfonylurea; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen Sulfonylurea - 10-100X more potent; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen Sulfonylurea - 10-100X more potent; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen Sulfonylurea - 10-100X more potent; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen Sulfonylurea - 10-100X more potent; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Meglitinide - benzoic acid deriv; Very rapid GI absorption;
 Inc insulin secretion;
 Short t1/2, used for post-prandial control
 Tx DM, promote hypoglycemia;
 SE - severe hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Meglitinide - benzoic acid deriv; Very rapid GI absorption;
 Inc insulin secretion;
 Short t1/2, used for post-prandial control
 Tx DM, promote hypoglycemia;
 SE - severe hypoglycemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biguanide; GI absorption - little first pass met.;
 Dec hepatic glucose production;
 No hypoglycemia, NO INSULIN AXN;
 SE - BLACK BOX lactic acidosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thiazolidindione; GI absorption - little first pass met.;
 Bind PPAR-gamma receptor, inc insulin sensitivity;
 Tx DM, promote hypoglycemia;
 SE - BLACK BOX MI risk
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thiazolidindione; GI absorption - little first pass met.;
 Bind PPAR-gamma receptor, inc insulin sensitivity;
 Tx DM, promote hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-glucosidase (brush border enzyme) inhibitor; Dec carbohydrate (starch) absorption;
 Dec post-prandial glu spike;
 Tx DM, promote hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-glucosidase (brush border enzyme) inhibitor; Dec carbohydrate (starch) absorption;
 Dec post-prandial glu spike;
 Tx DM, promote hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incretin- Works thru GIP/GLP-1 mechanisms, more potent; Synthetic version of exendin-4 (Gila monster);
 Inc insulin, dec glycogenolysis, dec gastric emptying, dec appetite, dec glucagon, some inc in beta cells - hypoglycemia!;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 'Incretin'; Inhibits dipeptidyl peptidase-4, inh inactivation of Incretins (GIP/GLP-1);
 -> Inc insulin, dec glycogenolysis, dec gastric emptying, dec appetite, dec glucagon, some inc in beta cells - hypoglycemia!;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amylin analog; Dec gastric emptying, inc satiety (@hypothalamus), inh glucagon;
 Weight loss and less insulin req.;
 Tx DM1 and DMII
 |  | 
        |  | 
        
        | Term 
 
        | Diazoxide (Proglycem) (ASMT 10 = CAPS ONLY)
 |  | Definition 
 
        | direct vasodilator, HYPERGLY AXN; tx HTN crisis, HYPOGLYCEMIA, INOPERABLE INSULINOMAS;
 INH INSULIN SECRETION;
 SE tachycardia, fluid retention, palpitations, HYPERGLYCEMIA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Somastatin analog - long acting; Inh insulin, glucagon, GH, and TSH release;
 Tx insulinomas, glucagonomas, acromegaly
 |  | 
        |  | 
        
        | Term 
 
        | Parathyroid hormone (+ 3 functions)
 |  | Definition 
 
        | Activates AC to inc cAMP; Inc plasma Ca by [1] inc bone resorption, [2] inc kidney reabsorption, [3] inc active VitD/calcitriol;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hPTH[1-34]; Activates AC to inc cAMP;
 Inc plasma Ca by [1] inc bone resorption, [2] inc kidney reabsorption, [3] inc active VitD/calcitriol;
 Tx hypoparathyroidism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Activates AC to inc cAMP; Inc plasma Ca by [1] inc bone resorption, [2] inc kidney reabsorption, [3] inc active VitD/calcitriol;
 Tx hypoparathyroidism
 |  | 
        |  | 
        
        | Term 
 
        | Synthetic human calcitonin (hCT) (+ 3 functions)
 |  | Definition 
 
        | Dec plasma Ca by [1] dec bone resorption, [2] dec kidney reabsorption, [3] dec active VitD/calcitriol; Dec osteoclast surface area;
 "Calcitonin tones down plasma Ca lvls";
 Tx hypercalcemia, Paget's dz, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Natural calcitonin from salmon; Dec plasma Ca by [1] dec bone resorption, [2] dec kidney reabsorption, [3] dec active VitD/calcitriol;
 Dec osteoclast surface area;
 "Calcitonin tones down plasma Ca lvls";
 Tx hypercalcemia, Paget's dz, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Natural calcitonin from salmon; Dec plasma Ca by [1] dec bone resorption, [2] dec kidney reabsorption, [3] dec active VitD/calcitriol;
 Dec osteoclast surface area;
 "Calcitonin tones down plasma Ca lvls";
 Tx hypercalcemia, Paget's dz, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inc plasma Ca by... Inc abs./uptake of P and Ca(primary);
 Inc calbindin;
 Inc kidney reabsorption;
 Inc bone resorption
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol mimetic; Vit D3 from fish liver oils;
 Remains in lipid stores for months;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol mimetic; sim to cholesterol;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol mimetic; after irradiation - Vit D2;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol mimetic; Conv in body to calcitriol;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol analog; Tx PSORIASIS(better than GCs), rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol analog - Reduced Vit D2; Injection, nasal spray;
 Less active, use inc dose;
 Tx OSTEOPOROSIS, rickets, osteomalacia, hypoparathyroid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol analog; MOA - dec PTH secretion;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol analog; MOA - dec PTH synthesis via gene expression;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inc plasma Ca by... Inc abs./uptake of P and Ca(primary);
 Inc calbindin;
 Inc kidney reabsorption;
 Inc bone resorption;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Bisphosphonate; Less effective orally;
 Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, hypercalcemia;
 SE - via IV admin, osteonecrosis of jaw (less common in 1st gen)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen. Bisphosphonate - more potent; Most common Rx for post-meno Tx;
 Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis;
 SE - via IV admin, osteonecrosis of jaw (less common in 2nd gen), irritation of esophagus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen. Bisphosphonate - more potent; Less effective orally;
 Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, hypercalcemia;
 SE - via IV admin, osteonecrosis of jaw (less common in 2nd gen), irritation of esophagus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen. Bisphosphonate - more potent; Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis;
 SE - via IV admin, osteonecrosis of jaw (less common in 2nd gen), irritation of esophagus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 3rd Gen. Bisphosphonate - HIGH POTENCY; Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, BONE CANCER;
 SE - via IV admin, osteonecrosis of jaw!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 3rd Gen. Bisphosphonate - HIGH POTENCY; Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, BONE CANCER;
 SE - via IV admin, osteonecrosis of jaw!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcimimetic - Ca sensing receptor mimetic; Binds allosterically to the receptor, suppresses PTH;
 Tx hyperparathyroid w/ PT-carcinoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds Ca; Cavity prophylaxis - benefits only if present during tooth development;
 Prevent blood clotting;
 Prevent osteoporosis;
 SE osteosclerosis, mottled enamel;
 NO cancer risk
 |  | 
        |  | 
        
        | Term 
 
        | Desiccated animal thyroid preps |  | Definition 
 
        | T4 and T3; Not preferred b/c of high variability;
 Causes growth, inc metabolism, inc HR;
 Must monitor lvls closely;
 Calorigenic, inc HR, cardiac contraction force
 |  | 
        |  | 
        
        | Term 
 
        | Liothyronine sodium (Cytomel tablets, Triostat injectable) |  | Definition 
 
        | L-T3 Note oral or injectable;
 Calorigenic, inc HR, cardiac contraction force
 |  | 
        |  | 
        
        | Term 
 
        | Carbimazole (Neo-mercazole) |  | Definition 
 
        | Thioureylene - anti-thyroid drug; Inh I organification(via peroxidases), can't bind to thyroglobulin;
 Tx hyperthyroidism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inh periph (liver, kidney, pituitary, brain) conv of T4->T3 via 5'-deiodinase block; Tx hyperthyroidism (off-label)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inh periph (liver, kidney, pituitary, brain) conv of T4->T3; Tx hyperthyroidism (off-label)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Activation via enzymatic reduction;
 Blocks pyruvate:ferrodoxone oxidoreductase;
 90% bioavail, BBB penetration, low protein binding;
 Tx - trichomonas, entamoeba h., giardia, anaerobes (B. fragilis, C. diff);
 SE - GI, HA, metallic taste, dizziness, disulfriam-like, anorexia, neuro tox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Inhibits electron transport, dec pyrimidine synth;
 99% protein bound, lipophillic, hydrophobic;
 Tx pneumocystic pneumonia, toxoplasma, entamoeba, trichomonas, P. falciparum
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Poor abs - IV, inhaled admin;
 Tx [2nd line]-  pneumocystis, leishmania, trypanosoma;
 SE [50%] - hypoT, hypoGly, blood dyscrasias, cardiotox, nephrotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Oral (50% bioavail) or IV admin;
 Inh ornithine decarboxylase to block polyamine synth;
 Tx - W. trypanosoma
 SE - anemia, leucopenia, diarrhea, convulsions, GI, alopecia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Poor abs;
 Aminoglycoside Ab;
 Tx - entamoeba, tapeworms, leishmanias, giardia (pregnancy);
 SE - diarrhea, iodine tox;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; IV, IM admin;
 MOA trypanothine redox system - rapid efflux of try. and GSH from cells, blocks try. reductase;
 Tx - leishmaniasis;
 SE - pancreatitis, myelosuppression, muscle pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Poor abs;
 Tx - tapeworms, luminal trophozoites;
 SE - diarrhea, iodine tox, GI (take w/ meals);
 CI - optic neuropathy, renal dz, thyroid dz;
 Preferred alternative is Paramomycin;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Rapid exretion, IV admin;
 Arsenic-containing, inh trypanothione reductase;
 Tx trypanosoma brucei (E. african meningoencephalic stage);
 SE [prevent w/ prednisone] - fever, reactive encephalopathy, peripheral neuropathy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Wide distribution, slow clearance (months);
 Resistance - efflux at P-gp;
 Tx - Plasmodium, non-GI amebiasis;
 Prophylactic use;
 SE - blurred vision (melanin binding, corneal deposits), retina pigmentation, hemolysis (if G6PD deficient);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Block DNA synthesis;
 Tx - P. falci, gametes of P. vivax and P. malariae;
 Poor therapeutic index;
 SE - dec heart contract., dilate vessels, contract uterus, vertigo, hemolysis (if G6PD deficient),
 Cinchonism - tinnitus, blurred vision, HA, dec hearing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide and antiarrhythmic; Block DNA synthesis;
 Tx - severe P. falci, gametes of P. vivax and P. malariae;
 SE - anticholinergic;
 CI - AV heart block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Oral admin, 98% bound, excreted in bile;
 Acts only @ asexual erythrocytic stages;
 Block DNA synthesis;
 Tx - P. falci, gametes of P. vivax and P. malariae;
 SE - GI, vertigo, convulsions;
 CI - BBs, chloroquine, quinine, quinidine, hx seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Acts only @ asexual erythrocytic stages;
 HIGH absorption when admin w/ [fatty] food (CI!);
 Tx - multi-resistant P. falci;
 SE - prolonged QT interval, arrhythmias;
 Variable absorption, time to peak [plasma], and elim
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Variable oral abs;
 Tx P. falci;
 Dec cardiotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide - from Chinese herb; Free radicals dmg macromolecules in Plasmodium;
 Tx - severe chloro-resistant Plasmodium [falci], leishmania, toxoplasma, schistosomiasis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide - Attack plasmodia in red blood cells preventing or terminating the clinical attack; Acts only @ asexual erythrocytic stages;
 |  | 
        |  | 
        
        | Term 
 
        | Malarone (Atovaquone/proquanil) |  | Definition 
 
        | Blood schizontocide - Attack plasmodia in red blood cells preventing or terminating the clinical attack; Acts @ asexual erythrocytic stages and primary liver stages;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tissue schizontocide, Gametocidal, Hypnozoitocidal; Rapidly abs and conv to Carboxyprim.;
 Tx - prophylaxis, P. vivax and P. ovale @ hepatic and gamete stages;
 KILLS P. FALCI GAMETES;
 CI - G6PD deficient (X-linked) leads to hemolytic anemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tissue schizontocide; High abs;
 Inhibits DHFR;
 SE - dec hematopoeisis, megaloblastic anemia;
 Never used alone, oft w/ Sulfadoxine
 |  | 
        |  | 
        
        | Term 
 
        | Fansidar (Sulfadoxine/Pyrimethamine) |  | Definition 
 
        | Tissue schizontocide axn; Tx - chloro-resistant P. falci, Toxoplasma;
 SE - fatal cutaneous rxns (incl erythema multi, SJS, epidermal necrolysis);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzimidazole - Anti-helmintic; Rapid met to albendazole sulfoxide;
 Inh carb transport and microtubule assembly - immobilization and death;
 Blocks larval development;
 Tx helmintics - ascariasis, enterobius, hookworm;
 SE - teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzimidazole - Anti-helmintic; Poor abs, highly bound;
 Inh carb transport and microtubule assembly - immobilization and death;
 Blocks larval development;
 Tx helmintics - ascariasis, enterobius (pin), Trichuris (whip), hookworm;
 SE - teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Inc Ca++ perm - spastic paralysis;
 Readily abs, hi first pass met, inc metabolites;
 Tx - tapeworms, schistosomiasis, 3 forms of fluke;
 SE - GI, HA;
 CI - Carbamazepine & Phenobarbital dec bioavail; Cimetidine inc bioavail, ocular schistosomiasis;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Oral admin, no met, long t1/2 (slow cl);
 Inc Cl perm. - inh glutamate and GABA-ergic channels - paralysis;
 Tx - strongyloidiasis, onchocerca (rvr blindness);
 SE - GI, itch, dizzy, inflamm rxn to dying bugs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Rapid GI abs;
 Tx lymphatic filariasis;
 SE - anorexia, nausea, HA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Poor abs;
 Bind N receptors - depol blockade - spastic paralysis (bug falls off GI wall);
 Tx - MONILIFORMIS, GI nematodes;
 Dec SE due to localization of drug in GI - HA, dizziness, rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bile acid sequesterants; Large tablet or powder, take w/ OJ;
 Anionic, binds (-) bile acids in GI - inh bile recycling - liver excretes more chol;
 Safe for children, hepatic dz;
 Dec LDL by 25%;
 SE - sandy texture, flatulence, hypertriglyceridemia, constipation, drug interaction;
 |  | 
        |  | 
        
        | Term 
 
        | Cholestyramine (Questran) |  | Definition 
 
        | Bile acid sequesterants; Powder form;
 Anionic, binds (-) bile acids in GI - inh bile recycling - liver excretes more chol;
 Safe for children, hepatic dz;
 Dec LDL by 25%;
 SE - sandy texture, flatulence, hypertriglyceridemia, constipation, drug interaction;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bile acid sequesterants; Tablet, more potent, forms hydrophilic gel, take w/ hi lvl of water;
 Anionic, binds (-) bile acids in GI - inh bile recycling - liver excretes more chol;
 Safe for children, hepatic dz;
 Dec LDL by 25%;
 SE - sandy texture, flatulence, hypertriglyceridemia, constipation, drug interaction;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Prodrug, conv at CYP3A4, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Prodrug, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases, INTERAXN @ CYP3A4;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Inc safety, low potency, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Inc safety, low potency, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Inc potency, dec renal cl, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases, INTERAXN @ CYP3A4;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Most potent statin, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholesterol absorption inhibitor; Blocks internalization of NPC1L1 - dec chol abs by 50% - dec hepatic chol - upreg of LDL receptors - dec LDL by 18%;
 SE - GI, fatuge, gallstones, Category C, inc liver enzymes;
 Inc lvls in elderly, female;
 CI - <10y.o., hepatic or renal insuff, lactation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fibrate - anti-lipid; Safe for renal, liver dz;
 Activate PPAR-alpha - FA oxidation, inc biliary chol excretion (Dec TG by 50%);
 Inc HDL (Apo-A1), no effect on LDL!;
 Dec MI/CHD morbidity;
 SE - gallstones, reflux, diarrhea, myopathy (if w/ statin);
 Blocks hepatic met of all statins - inc metabolites;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fibrate - anti-lipid; Active met - fenofibric acid - glucaronidation;
 Activate PPAR-alpha - FA oxidation, inc biliary chol excretion (Dec TG by 50%);
 Inc HDL (Apo-A1), no effect on LDL!;
 SE - gallstones, inc transaminases, dec GFR, azotemia;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-lipid; Dec FFA mobilization - dec TG & ApoB synth (dec VLDL), inc HDL transport, enhanced LPL;
 Dec LDL by 25%, Dec TG by 50%, Dec Lp(a);
 Dec CHD/MI incidence;
 SE - hepatotox (inc enzymes), flushing, conjunctivitis, retinal detach, inc insulin resistance (a. nigricans), gout, dry skin, Category C, pruritis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Omega-3 FAs - ALA, EPA, DHA; Dec TGs (35%), antiplatelet, hypotensive, antiarrhythmic;
 Dec CHD
 |  | 
        |  |